Long Island Clinical Research Associates, LLP
Great Neck, New York 11021
0 studies enrolling now · 20 studies all time
What they study most
Chronic Constipation, Crohn Disease, Crohn's Disease, Diarrhea Predominant Irritable Bowel Syndrome, Inflammatory Bowel Disease, Intestinal Fistula, Irritable Bowel Syndrome With Constipation, Narcolepsy, Opioid-Induced Bowel Dysfunction, Shift-Work Sleep Disorder, Sleep Apnea Syndromes, Sleep Apnea, Obstructive
Studies at this site
- Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's Disease — Completed
- An Open Label Safety and Tolerability Study of AIN457 in Patients With Moderate to Severe Crohn's Disease — Stopped early
- Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis — Completed
- Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease — Completed
- A Study To Monitor Long-Term Treatment With PF-00547659 — Completed
- Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone — Completed
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation — Completed
- Evaluating a Shared Decision Making Program for Crohn's Disease — Completed
- Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo — Completed
- A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn's Disease — Completed
- Safety and Efficacy of Natalizumab in Combination With Remicade in the Treatment of Crohn's Disease — Completed
- A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease — Stopped early
- Safety and Efficacy of AST-120 in Mild to Moderate Crohn's Patients With Fistulas — Completed
- Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) — Completed
- Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder — Completed
- Safety and Tolerability of Single Doses Oral CNDO 201 Trichuris Suis Ova in Patients With Crohn's Disease — Completed
- Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's Disease — Stopped early
- FACTS II: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis — Completed
- CP-461 for the Treatment of Crohn's Disease — Completed
- Efficacy and Tolerability Study of Natura-Alpha in the Treatment of Patients With Active Ulcerative Colitis — Status unconfirmed